rs41304351

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.525+12G>C variant in the PTPN11 gene is 1.4% for European (Non-Finnish) chromosomes by the Exome Aggregation Consortium (969/66644 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). Additional case level data available: SCV000057399.8; SCV000061311.5; SCV000248623.2; SCV000206755.1; SCV000207666.1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA134671/MONDO:0021060/004

Frequency

Genomes: 𝑓 0.010 ( 17 hom., cov: 32)
Exomes 𝑓: 0.013 ( 147 hom. )

Consequence

PTPN11
NM_002834.5 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:19

Conservation

PhyloP100: -1.29

Publications

4 publications found
Variant links:
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]
PTPN11 Gene-Disease associations (from GenCC):
  • LEOPARD syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • metachondromatosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
NM_002834.5
MANE Select
c.525+12G>C
intron
N/ANP_002825.3
PTPN11
NM_001330437.2
c.525+12G>C
intron
N/ANP_001317366.1Q06124-1
PTPN11
NM_001374625.1
c.522+12G>C
intron
N/ANP_001361554.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
ENST00000351677.7
TSL:1 MANE Select
c.525+12G>C
intron
N/AENSP00000340944.3Q06124-2
PTPN11
ENST00000635625.1
TSL:5
c.525+12G>C
intron
N/AENSP00000489597.1Q06124-1
PTPN11
ENST00000392597.5
TSL:1
c.525+12G>C
intron
N/AENSP00000376376.1Q06124-3

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1563
AN:
152204
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0219
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0150
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0100
AC:
2522
AN:
251322
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.00197
Gnomad AMR exome
AF:
0.0136
Gnomad ASJ exome
AF:
0.00635
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00222
Gnomad NFE exome
AF:
0.0156
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.0134
AC:
19579
AN:
1461052
Hom.:
147
Cov.:
31
AF XY:
0.0130
AC XY:
9453
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33462
American (AMR)
AF:
0.0143
AC:
641
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00808
AC:
211
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39686
South Asian (SAS)
AF:
0.00199
AC:
172
AN:
86240
European-Finnish (FIN)
AF:
0.00281
AC:
150
AN:
53414
Middle Eastern (MID)
AF:
0.00360
AC:
20
AN:
5550
European-Non Finnish (NFE)
AF:
0.0158
AC:
17540
AN:
1111494
Other (OTH)
AF:
0.0131
AC:
789
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
892
1785
2677
3570
4462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1560
AN:
152322
Hom.:
17
Cov.:
32
AF XY:
0.00960
AC XY:
715
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00267
AC:
111
AN:
41578
American (AMR)
AF:
0.0218
AC:
334
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0150
AC:
1022
AN:
68036
Other (OTH)
AF:
0.0147
AC:
31
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
80
160
241
321
401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0113
Hom.:
2
Bravo
AF:
0.0117
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
4
not provided (4)
-
-
2
Metachondromatosis (2)
-
-
2
RASopathy (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Juvenile myelomonocytic leukemia (1)
-
-
1
LEOPARD syndrome 1 (1)
-
-
1
Noonan syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.22
DANN
Benign
0.48
PhyloP100
-1.3
PromoterAI
0.0076
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41304351; hg19: chr12-112891203; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.